211 related articles for article (PubMed ID: 19652382)
1. Effects of angiotensin receptor blocker on oxidative stress and cardio-renal function in streptozotocin-induced diabetic rats.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Suzuki K; Tachikawa H; Kodama M; Aizawa Y
Biol Pharm Bull; 2009 Aug; 32(8):1411-6. PubMed ID: 19652382
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats.
Anbar HS; Shehatou GS; Suddek GM; Gameil NM
Eur J Pharmacol; 2016 Jun; 780():82-92. PubMed ID: 27012991
[TBL] [Abstract][Full Text] [Related]
3. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
Anjaneyulu M; Chopra K
Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity.
Manni ME; Bigagli E; Lodovici M; Zazzeri M; Raimondi L
Pharmacol Res; 2012 Apr; 65(4):465-71. PubMed ID: 22123499
[TBL] [Abstract][Full Text] [Related]
6. The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro.
Zhang W; Miao J; Wang S; Zhang Y
PLoS One; 2013; 8(5):e63472. PubMed ID: 23658831
[TBL] [Abstract][Full Text] [Related]
7. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
8. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
[TBL] [Abstract][Full Text] [Related]
9. The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats.
Kamper M; Tsimpoukidi O; Chatzigeorgiou A; Lymberi M; Kamper EF
Transl Res; 2010 Jul; 156(1):26-36. PubMed ID: 20621034
[TBL] [Abstract][Full Text] [Related]
10. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
11. Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes.
de Cavanagh EM; Ferder L; Toblli JE; Piotrkowski B; Stella I; Fraga CG; Inserra F
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H456-65. PubMed ID: 18024545
[TBL] [Abstract][Full Text] [Related]
12. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats.
Yang R; Yang B; Wen Y; Fang F; Cui S; Lin G; Sun Z; Wang R; Dai Y
J Sex Med; 2009 Mar; 6(3):696-707. PubMed ID: 19175863
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats.
Kedziora-Kornatowska K
Clin Chim Acta; 1999 Sep; 287(1-2):19-27. PubMed ID: 10509893
[TBL] [Abstract][Full Text] [Related]
14. Losartan reduces myocardial interstitial fibrosis in diabetic cardiomyopathy rats by inhibiting JAK/STAT signaling pathway.
Wang L; Li J; Li D
Int J Clin Exp Pathol; 2015; 8(1):466-73. PubMed ID: 25755735
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
18. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
[TBL] [Abstract][Full Text] [Related]
19. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
